Cypralis, a life sciences company focussed on the discovery of novel therapeutics based on modulation of peptidyl-prolyl isomerases (PPIases) has acquired a portfolio of cyclophilin inhibitor assets from SCYNEXIS Inc, a NASDAQ-listed company headquartered in New Jersey, USA.
Wed, 13/07/2016 - 15:00
Mon, 11/07/2016 - 16:00
Pearson Medical Technologies, a leader in pharmacy automation solutions, will showcase at RBC Cardinal 2016 in Chicago, IL from July 20-23 with XchangeLabs.
Thu, 09/06/2016 - 13:45
Advanced cell-line technology could reduce costs of vaccine production.
Wed, 25/05/2016 - 09:00
Selcia opens new state-of-the-art API radiolabelling laboratory.
Thu, 05/05/2016 - 09:00
Mercia has committed follow-on capital to Medherant Ltd. Medherant’s patch, known as the TEPI-patch®, is a thin, strong, easy-to-apply and easy-to-remove patch capable of delivering higher doses of drugs.
Tue, 26/04/2016 - 09:00
Queen’s University Belfast and Domainex Ltd secure funding from the Wellcome Trust to accelerate early development of first-in-class FLIP inhibitors.
Tue, 19/04/2016 - 09:00
Johnson Matthey and Domainex have announced a collaboration to provide integrated small molecule pharmaceutical discovery and development services.
Wed, 02/03/2016 - 09:00
Cypralis appoints Dr Michael Peel as Chief Scientific Officer.
Wed, 10/02/2016 - 13:00
Advanced Electrophoresis Solutions Ltd. is pleased to announce Isogen Life Science B.V. as the exclusive distributor of its products in Europe.
Wed, 03/02/2016 - 09:00
Domainex Ltd is pleased to announce that the recipient of its latest Discovery STAR Award is Dr Aude Echalier, Lecturer in Structural Biology of Cancer Related Targets at the University of Leicester.